The BVA is calling on Defra and the APHA to take an innovative approach to capturing farm animal post-mortem data, after its Voice of the Veterinary Profession survey found that 90% of production animal vets now conduct their own PMs.
In 2014, there was a 31% increase in production animal vets carrying out their own PMs following post mortem laboratory closures, yet most vets keep this PM data at their practice, with less than 5% inputting it into a national system such as NADIS, AHT or APHA and less than 1% to a benchmarking group.
Sean Wensley BVA President said: "We have heard a lot about big data and its positive uses economically and socially. Disease surveillance could be a shining example of where big data and innovative data capture comes into its own. In a global world, where diseases such as Schmallenberg and bluetongue can emerge in our livestock without having previously been seen on these shores, being able to quickly join up the dots of disparate disease data is vital.
"We understand that Defra and APHA must make difficult choices due to economic pressures and we very much welcome research already utilising post mortem data such as the Agriculture and Horticulture Development Board’s Fallen Stock Project. What we now need is clear communications and guidance on carcase collection and access to PM examination arrangements together with a determination to see this as an opportunity to innovate, exploring how digital technology can help vets in the field record and capture data that feed into national databases and help us to see the bigger picture."
BVA is asking that all vets affected by laboratory closures are clearly informed about alternative arrangements for carcase collection and PMs, with 63% of vets affected by laboratory closures reporting that carcase collection in their local area was not working well.
BVA is calling on government and industry to lead in developing new and cost efficient ways to capture and analyse disease and surveillance data, drawing on innovations in digital technology and big data analysis.
Photograph courtesy BVA
A group of UK-based investigators from Davies Veterinary Group and the UCL School of Pharmacy has published the results of a study which suggests Keppra (levetiracetam) shows promise for the treatment of feline audiogenic reflex seizures (FARS).
The condition, which was first documented by the same investigators last April, affects older cats which typically exhibit myoclonic seizures (brief, shock-like jerks of a muscle or a group of muscles) in response to certain high-pitched sounds. Both non-pedigree and pedigree cats (in particular, Birmans) may be affected. A range of sound stimuli has been reported, including the crinkling of tin foil and a metal spoon dropping into a ceramic feeding bowl, through to firewood spitting and even texting on a phone. While avoiding the triggering sounds can reduce the incidence of seizures, this is not always practical, so this research is potentially good news for owners of affected cats.
The study, Levetiracetam in the management of feline audiogenic reflex seizures: a randomised, controlled, open label study, has been published in the Journal of Feline Medicine and Surgery1.
It compared the efficacy of two antiepileptic drugs, levetiracetam (a relatively novel medication that has proven effective in studies of people with generalised epilepsies that experience myoclonic seizures) and the much older first generation drug phenobarbital, in 57 cats diagnosed with FARS. Cats were treated with one or other drug over a 12 week period; and owners were asked to record the date, number and type of seizures, any signs of illness, side effects and changes in activity or attitude, as well as whether they thought their cat's quality of life had improved, remained the same or deteriorated since starting the medication.
All cats receiving levetiracetam showed a reduction in the number of days that they experienced myoclonic seizures by at least half. In comparison, only 3% of cats showed the same reduction when treated with phenobarbital. The majority of reported side effects, such as lethargy and inappetence, were mild to moderate in both groups and these resolved after about 2 weeks in the cats treated with levetiracetam; in the phenobarbital group, however, side effects were relatively persistent. Owners of cats treated with phenobarbital perceived no benefit from using the medication; in contrast, all of the owners of cats treated with levetiracetam commented that their cat appeared brighter and more responsive after the first couple of weeks of treatment. Moreover, five cats treated with phenobarbital were switched to levetiracetam after the study, as their owners desired improved seizure control.
Having established that levetiracetam is an effective and well-tolerated treatment for cats with hallmark myoclonic seizures, the next step is to identify whether levetiracetam will also prevent so-called generalised tonic–clonic seizures. This is another seizure type seen in cats with FARS, and is what most people think of as a 'seizure', with the cat losing consciousness and its body stiffening and jerking, often for several minutes.
Lead author on the paper, Mark Lowrie, said: "It is great to find a medication that works so well at controlling these seizures. Levetiracetam is not licensed in cats but it has proven to be a very safe drug. For affected cats to benefit, it is important that vets recognise the signs as this newly defined syndrome of FARS and that this medication is used in preference to other, less efficacious, anti-epileptic drugs."
Reference
Medivet senior partner Adi Nell says the profession needs to consider new business models to encourage more vets into ownership, as well as fresh approaches to supporting the role.
Responding to issues and recommendations highlighted in the latest VetFutures report, such as the number of female practice owners and a perceived lack of business skills in the profession, Adi said practices need to be flexible when it comes to attracting new vets or owners.
"Client expectations have changed drastically in the past 15 years, but so have the desires of potential practice owners. The world of clinical practice is changing at a rate we’ve never seen before. Owning a practice, along with the other increasing demands on our limited time and energy, is becoming more of a challenge too. This is evident with the growth of business support and development services, indicating an increased demand for that support.
"New practice owners aren’t like previous generations. Although traditional models of ownership are changing gradually, we also need different models of working, such as flexible hours, and different methods of support are needed."
One of the trends noted in the 2014 VetFutures report was how, despite dominating the profession in terms of overall numbers, women are still less likely to be a sole principal, director or partner.
Medivet claims an excellent track record here, with a near 50/50 split of male and female branch owners/partners.
Adi added: "We’re very happy to have so many women as business partners with us. The combination of clinical freedom, business support and a real feeling of teamwork and care for each other are some of the features that enable our partnership model to work so well. The scope for clinical and business development is huge, and we do our very best to look after all our people as they grow.
"However, there are still far too many bright, talented and highly trained vets leaving the profession after too short a time. Why do we turn these diamonds into coal? We need to understand what’s driving this and how we can adapt. The VetFutures report starts to offer some of the answers – and has uncovered even more questions!"
The VetFutures report also found aspirations of practice ownership or partnership dropped from 45% among students to 25% once vets start work. Adi says that offering opportunities for vets to expand into other areas of expertise is key to reducing the decline in appetite for practice ownership. He said: "I started out offering dermatology referral services to various Medivet branches before becoming a branch partner myself. I’m now in charge of a Medivet region of 16 practices as well as being involved in strategy, marketing, HR and operations, which I absolutely love, but never predicted I would do.
"I believe fewer and fewer vets see themselves doing the same job in clinical practice for their entire careers. That includes not wanting to be an employee for life, but also not wanting to have all the responsibility and burden of individual practice ownership. A big group like Medivet allows them to find the niche they enjoy and to develop the skills they value, to the benefit of their own careers, their business success, their client care and their patients’ health."
Henry Schein Inc. has announced an agreement to acquire RxWorks Inc., the veterinary practice management software provider.
Founded in 1988 and with headquarters in Brisbane, Queensland, Australia, RxWorks has 68 team members and an installed base of more than 1,500 veterinary clinics in 19 countries worldwide (primarily Australia, New Zealand, the UK and the Netherlands).
Henry Schein says RxWorks will become part of it's Global Animal Health Practice Solutions business, led by its current management team.
Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, Henry Schein, Inc. said: "RxWorks has an excellent reputation for helping veterinarians increase practice efficiency and improve quality health care through its innovative practice management software solutions.
"The addition of RxWorks further strengthens our growing practice management software solutions business, which helps deepen relationships in the regions served by RxWorks with our animal health customers, including large corporate customers. The addition of RxWorks will nicely complement our expanding animal health technology businesses. We look forward to welcoming our new colleagues from RxWorks to Henry Schein."
Nathan Basha, Chairman of RxWorks said: "RxWorks software is designed to facilitate consistency of patient care, enable practice growth, achieve enhanced profitability and optimize professional time, all the while improving the quality of life for patients. Aligning with Henry Schein, a global company committed to serving animal health professionals and bringing innovation to the marketplace, allows RxWorks to provide even further value to customers while expanding industry reach."
Henry Schein says it expects the acquisition to close in the second half of January 2016. Financial details and terms of the transaction were not disclosed.
Assistance dog charity Canine Partners is asking the profession to support its work by taking places on a number of fund-raising challenges this year, including the Reading Half Marathon, Brighton Marathon, Tough Mudder, Ride London, Forth Road Bridge Abseil and Para Tri.
Holly Bryan, Events and Challenge Co-ordinator, said: "We are looking for people of all abilities who are willing to take on a challenge this year in aid of Canine Partners. All we ask is that you give something back by raising money for us through sponsorship.
"We have places available for many events during 2016 but we can also support you if you have your own place and wish to fundraise for Canine Partners.
"This year we are delighted to announce that we are an official charity of the Reading Half Marathon and our gold package means that we have 30 guaranteed places as well as use of the Reading FC Players’ Lounge.
"By supporting Canine Partners you will be joining our amazing ‘purple army’ team who are helping us to change people’s lives for the better."
The national charity trains dogs to help with everyday tasks disabled people would otherwise find difficult, painful or impossible including opening doors, undressing, pressing buttons, unloading the washing machine and fetching help in an emergency. The assistance dogs also increase independence, confidence and provide loving companionship.
Paul Sparrow, who ran the London Marathon for Canine Partners last year, said: "The support I have received from the crowds and the charity were fantastic and if one person saw my vest and googled Canine Partners to learn more about them, then it will have been worthwhile."
For more information, visit caninepartners.org.uk/challenges, or contact Holly at: hollyb@caninepartners.org.uk or call 01730 716013.
Zoetis has launched a one-dose vial of Rispoval IntraNasal, in order to offer respiratory health protection in calves as soon as possible after birth without either waiting to batch them in groups or wasting unused vaccine in multi-dose packs.
To make ready for use, the vaccine is reconstituted by mixing a powder with sterile diluent. Once mixed, the licensed shelf life is two hours. This means any that is unused in multi-dose packs must be thrown away. By stocking a combination of one- and multi-dose packs, farmers can eliminate this.
The vaccine protects against two primary viral causes of pneumonia in young calves, BRSv and Pi3v1. Surveillance of blood samples from 2,145 calves with pneumonia signs found 78% exposed to BRSv, 81% to Pi3v2. The product licence allows use from nine days of age, with onset of immunity to BRSv and Pi3v after five and 10 days respectively. The licence also specifies a duration of immunity of 12 weeks.
Zoetis vet Carolyn Hogan says that viruses are the instigator of a majority of respiratory health problems: "Early-life protection also helps reduce the threat from opportunistic secondary bacterial infections, such as Pasteurella.
"Good respiratory health is essential to ensure calves develop to achieve their lifetime potential. But it's estimated that 67% of pneumonia cases occur in calves less than three months of age3.
"Whether suckled or reared, calves that don’t grow effectively in the early weeks are unlikely to catch up later. On both dairy and beef units, proactive management of the calf living space, nutrition and disease resilience is critical to maximise lifetime productivity, which is clearly so important under today's farm business economics.
More information about the benefits of managing respiratory health in calves is available at plantoproduce.co.uk.
Virbac has launched Propofol-Lipuro Vet, a short-acting intravenously administered and short-term maintenance general anaesthetic for use in dogs and cats.
Propofol-Lipuro Vet contains no preservatives so its use can be repeated, even in cats, for continuous rate infusion. No age restrictions apply to the animals it can be used for and it can be administered for induction prior to Caesarean section.
Virbac Product Manager Kate Woolley MRCVS said: "Propofol is a well-established solution for short-acting anaesthesia in many practices. Propofol-Lipuro Vet complements Virbac's anaesthesia range which now offers total control of analgesia, sedation, intravenous and gaseous anaesthesia, and recovery."
Propofol-Lipuro Vet is available in boxes of 10 x 20 ml bottles.
Ceva Animal Health has extended its Meloxidyl dogs and cats’ range with the launch of a new 5ml Meloxidyl oral suspension for cats.
The company says the new bottle size will provide more prescription options for veterinary practices currently stocking 15ml bottles and is a perfect post-surgery size to send patients home with. The bottles are also clear brown in colour; designed to make it easier for cat owners to see how much liquid is left in each bottle.
Meloxidyl oral suspension for cats contains meloxicam for the alleviation of pain and inflammation. It is licensed for the treatment of musculo-skeletal disorders and the alleviation of post-operative pain.
Rob McLintock, business unit manager at Ceva Animal Health said: "The new 5ml Meloxidyl oral suspension for cats’ bottle will provide veterinary practices with more prescription options for the management and alleviation of pain and inflammation in cats."
To support the launch of the new 5ml Meloxidyl presentation, Ceva is running a competition to win one of five BSAVA Manuals of Anaesthesia and Analgesia by answering one question: ‘How many millilitres are in the new Meloxidyl cat bottle’?
To enter the competition, email analgesics-group@ceva.com. Include ‘Meloxidyl competition’ in the subject line and contact details and the answer to the question in the main body of the email.
For further information on Ceva’s analgesic product range, contact your local Ceva territory manager, email analgesics-group@ceva.com or call 01494 781510.
VetSurgeon.org has launched a completely revamped classified jobs section for the profession which allows members to subscribe for alerts when someone advertises a vacancy in their area.
VetSurgeon Jobs has been designed from the ground up to be as simple as possible for job-seekers to find the right vacancy. By default, jobs are listed in the order they were posted. But enter a location (ideally your postcode) and the list re-orders by distance from that location. Simple as that. No login required.
You can also set other criteria, such as small animal vet jobs only, to further whittle down the selection.
The subscription service works on the same basis. In most cases, you'll probably just want to enter a postcode and a distance from that postcode that you're interested in. But you can also add further filters so you are notified only of, say, locum or small animal positions. And for those locums who work in multiple locations, you can set up multiple subscriptions.
For advertisers, we thought of only one thing, which was how can we offer more bang for your buck than the alternatives (besides being presented on the most popular veterinary website for eight weeks). That question influenced every aspect of the design and functionality of the new, improved VetSurgeon Jobs.
In due course, VetSurgeon.org will introduce a charge for advertising. However, the site is and always has been about supporting the profession, and the pricing will reflect that: no more than £150 +VAT in 2016.
Virbac has announced the launch of Speed Trio, an in-house diagnostic test to enable the detection of FeLV (Feline Leukaemia Virus) antigens; anti-FIV (Feline Immunodeficiency Virus) and anti-FCoV (Feline Coronavirus) antibodies in 15 minutes.
The company says Speed Trio is designed to facilitate the diagnosis of immunosuppressive diseases, such as FIP (feline infectious peritonitis); when a cat tests positive for Feline Coronavirus and either FeLV or FIV it is at increased risk of developing FIP¹ and serological testing for all three diseases is the logical step.
Virbac says it has also enhanced the entire Speed range to further improve the readability of the tests and the brightness of the test bands.
Product Manager Madeline Haynes said: "The Speed range, which has been proven in practice for more than 20 years, offers a comprehensive suite of in-house diagnostic tests, which are easy to perform and highly cost-effective to use in practice.
"Speed Trio is not only a unique test combination that helps to facilitate diagnosis of immunosuppressive diseases but also boosts client satisfaction and can support practice profitability."
Recent graduate, Sophie Gumble, from Head & Head Vets in Helston, Cornwall, has won a week for two in a luxury cottage in Cornwall.
Sophie won the prize after entering a draw run by Vetlife at the Veterinary Defence Society recent graduate meetings and the SPVS Lancaster Final Year Students’ Seminar last year.
The competition is run annually to raise awareness amongst younger members of the profession about the support that Vetlife provides through its support services: Vetlife Health Support, Vetlife Helpline and Vetlife Financial Support.
The prize, which was generously donated by former Vetlife Director Nicky Paull, will be offered again at the VDS reunions in 2016.
Sophie said: "I am a 2014 Liverpool graduate from Herefordshire, who entered the competition at the VDS reunion. The weekend was very useful and a great opportunity to catch up with friends and revive crazy dance moves!
"It has been a big move down to Cornwall. The busy life of a new vet, coupled with many weekends racing up the M5 to help with the family farm, has meant I am yet to really get the chance to enjoy and explore what the county of pasties and Poldark has to offer! I am excited to now have the chance to explore new parts of this wonderful county!"
The VET Festival has announced its speaker line-up for this year's event, taking place on the 3rd & 4th June at Loseley Park in Guildford, Surrey.
The 21 hand-picked speakers include respected opinion formers from across the USA, Canada and the UK who are veterinary specialists and experts in fields including clinical & surgical orthopaedics, soft tissue surgery, medical & surgical oncology, neurology & neurosurgery, minimally invasive surgery & diagnostics, anaesthesia, diagnostic imaging, physiotherapy, sports medicine & rehabilitation, anaesthesia & critical care, nutrition, feline medicine & surgery and practice management & team building.
The organisers say this is a unique and unrivalled opportunity to hear, learn and network with some of the greatest minds in the veterinary world at a dynamic and engaging two-day outdoor conference designed for veterinary surgeons, veterinary nurses, veterinary rehab practitioners, practice support staff, managers and allied veterinary professionals working in companion animal practice.
Internationally-based speakers not available on the usual speaker circuit for primary care clinicians, include:
The 2016 conference will also welcome thought leaders currently practicing here in the UK, including:
There will be a focus on minimally invasive diagnostics and surgery lead by Phillip Mayhew from the University of Davis California and Elise Robertson will talk about minimally invasive endoscopy techniques in cats whilst Michael Kowaleski from Tufts University, Boston, and Noel Fitzpatrick will talk about arthroscopy of joints. There will also be a specific focus on diagnostic imaging with Russell Tucker from Washington State University sharing his nearly 40 years of experience with radiography, MRI and CT. Cancer is a huge area of increased interest in small animal practice currently and will be explored by a world-class team including Julius Liptak, Nick Bacon and Laurent Findji.
The growing importance of practice management and team-building prompted organisers to ask Brian Faulkner from the UK and Ernie Ward from the USA, both internationally recognised leaders in veterinary business training, to set up a mini-symposium in management and motivation. The objective is to keep the lectures practical and give delegates information that they can use every day, not just facts and figures.
Unlike conventional conferences, the VET Festival is staged outdoors in marquees alongside festival food and drinks and companies and organisations showcasing new technologies and products. Organisers say that this unique ‘fresh air’ festival environment creates a relaxed and fun atmosphere which is more conducive to learning and networking. There will be live music on both nights of the Festival with multiple bands contributing to the festival atmosphere, culminating in the ONE LIVE music concert on the final night.
For more information and to register for an early bird delegate discount visit www.vetfestival.co.uk
The Pet Epilepsy Tracker, an app developed by the RVC to help pet owners monitor their dog's condition and response to treatment, is to be translated into seven languages and offered throughout Europe.
Launched during National Epilepsy Week in May last year, the Pet Epilepsy Tracker was developed in collaboration with the Epilepsy Society.
Holger Volk, Professor of Veterinary Neurology and Neurosurgery at the RVC said: "The main advantage for owners will be the control of an unpredictable and previously uncontrollable disease. Additionally, vets will gain a greater understanding of medication given to a dog, with a record that allows them to spot patterns in seizures.
"The medication reminders increases an owner’s compliance by informing them how many seizures the dog had, which will in turn decrease trips to vets to monitor the disease."
Professor Volk added: “There are a few epilepsy apps in the human market but there was nothing like it for the dog market, until this app. I was proud to have been a part of the project and I am thrilled that this app will benefit pet owners in Europe as well as the UK."
The app will be demonstrated at this year’s ESVN/ECVN Symposium being held in Edinburgh (September 15-17) of which Professor Volk is the co-chair of the Scientific Programme.
The app is currently available to download in English on the Google Play store and Apple iTunes App Store. A video of Professor Volk discussing the app can be viewed at: https://youtu.be/bZDa_8a_hwM
Twycross Zoo has released a video on YouTube in which Sarah Chapman, Head of Veterinary Sciences, describes the challenges of being a zoo vet, explains why she loves the job and introduces the zoo’s partnership with the vet school at University of Nottingham.
The video is part of a six-part series of behind-the-scenes videos in which viewers can see some of the 500 animals in its care and the people that keep the zoo running from day to day. In addition to explaining the role of the veterinary team, the videos also explore the role of the zoo’s keepers and the research, conservation, education and animal training that takes place.
Locum vets Cristiana and Marco Tudini have had the holiday of a lifetime after winning a competition run by the recruitment consultants, Recruit4vets.
The couple, who came to the UK in 2006, were amongst 1000 people who entered the draw last year, when Cristiana was working for Companion Care in Folkestone.
Kelly Worrall from Recruit4vets said: "Our team called Cristiana on a typical day in the practice to deliver the news. She was obviously thrilled to get the call. Not only did we help find Cristiana her dream job, we sent her on a dream holiday too!"
Cristiana said: "My husband and I went to New York at the beginning of December. New York was full of festivities and was magical to go around Christmas time, we even visited Rockefeller Centre and watched the lights and singers. My husband and I are vegan, so we were delighted to find NYC filled with vegan restaurants and fast food outlets, we didn’t stop eating the whole trip!
"New York City was absolutely amazing, this really was a dream come true!"
The PDSA has announced that it is offering free workshops to help veterinary professionals deliver new welfare checks called 'PetWise MOTs'.
The PetWise MOT checks focus on the five welfare needs, and the workshops count for seven hours CPD. The charity says that while the workshops are suitable for all members of the practice team, they should be of particular interest to nursing teams and those with a keen interest in engaging clients with the needs of their pets.
The aim of the MOT Checks is to improve pet wellbeing in the UK, following reports of a reduced level of awareness amongst the public of the five welfare needs defined by the Animal Welfare Acts.
Richard Casey, PDSA Pet Wellbeing Project Manager, said: "We know there is more to a pet’s wellbeing than just providing for their basic health needs. This unique consultation structure was developed in response to falling awareness among owners of their pets’ welfare needs, with millions of pets suffering unnecessarily. The PetWise MOTs use a simple traffic light system and personalised action plans to reverse this trend by helping to inform and engage owners about what their pets need to be healthy and happy."
The consultations were first trialled on the charity’s mobile PetCheck vehicles, then expanded to PDSA’s 51 pet hospitals. According to the charity, over 100,000 PetWise MOTs and follow up checks have now been completed in the last few years, with outcomes including:
Alison Case, a Senior Vet at Bow PDSA Pet Hospital, said: "PetWise MOTs give a really practical approach to running clinics based on the pet’s welfare needs. We’ve seen a positive impact on patient care by looking at husbandry at home as well as the clinical concerns of the patient. The consultations help to strengthen the clinic-client bond through professional support and advice. We’ve had great feedback from our clients, who are now much more aware of the routine needs of their pets and often attend for further check-ups as well as regularly purchasing preventive treatments."
The workshops will focus on dogs, cats and rabbits, although the consultations are transferable to all species.
For more information or to book a place, visit www.pdsa.org.uk/petwise or email petwise@pdsa.org.uk.
Eukanuba has published the results of a 10 year study to evaluate the health and longevity of continuously Eukanuba-fed dogs, in which 90% lived beyond the breed's typical lifespan.
Before the start of the study, a independent panel of veterinary academics and experts assessed existing evidence concerning the longevity of Labrador Retrievers and came to a consensual conclusion that the average lifespan for the breed is 12 years.
39 Labrador Retrievers in early to mid-adulthood were then enrolled in the study1, which began in 2004. All the dogs were neutered and had identical housing, standardised daily care and veterinary care. The dogs were fed the amount of food needed to maintain each dog within an optimal body condition score.
Remarkably, 28% of the dogs in the study achieved exceptional longevity, living beyond 15.6 years. One dog very nearly made it to 18 years of age.
The study was overseen Eukanuba's Longevity Council, a panel of international vet and industry experts including Professor Stuart Carmichael, Dr Penny Watson, Dr Vicki Adams, Professor Steve Dean and David Morgan, which collectively agreed that the secret to healthy ageing in canines is a careful balance of nutrition, good husbandry and effective veterinary care.
Professor Steve Dean, Former Chairman of the UK Kennel Club said: "Nutrition is a major contributor to the health of dogs in the long term, of course it isn’t the only contributor; good husbandry and good veterinary care are the other major pillars for health and longevity. The correct nutrition has a big part to play in maintaining dog health throughout its entire life, which we’ve found out from the Eukanuba Long Life Observation, can be a lot longer than we have previously expected. We’ve always assumed that Labradors will live 12 years if we’re lucky, but now we have a whole new target to aim for…16 and 17 years. It is quite phenomenal."
Dr Penny Watson, Senior Lecturer in Small Animal Medicine, Queen’s Veterinary School Hospital, University of Cambridge said: "Vets as a profession are very good at treating diseases in animals, but perhaps slightly less good at giving preventative advice to pet owners about healthy lifestyles. As vets, we should be thinking all through an animals life cycle, from puppy to geriatric, about the preventative aspects, such as good diet, maintaining the right body condition score and other aspects including dental care, rather than just looking disease and treating it."
David Morgan, Eukanuba’s Senior Scientific Communications Manager said: "The hope is that we can take the message that it’s not only about nutrition but what we call appropriate care, which is veterinary care and husbandry, looking after the dogs in a responsible way. Because, yes we have some great observations and we are starting now with Dr Vicki Adams to break down into more detail what we’ve actually seen in the Eukanuba Labradors and what recommendations we can give in the future so that all dogs can have that longer, healthy and more vibrant lives."
Virbac has announced the launch of Canigen Lepto4 vaccine, which covers an additional two strains of Leptospirosis over its existing Canigen Lepto2 vaccine.
The company says the new product is designed to give practices the flexibility to meet the needs of certain high-risk groups in the UK and in dogs which may be travelling abroad.
Both vaccines are offered with technical training and support from Virbac. This includes a suite of educational and promotional resources to enable practices to engage with their clients and help to make informed decisions about Leptospirosis vaccination for their dog.
Sarah Walker MRCVS, Product Manager, said: "We are committed both to providing our practices with a full and flexible range of canine vaccines and to offering them all the support they need to advise their clients effectively on this important issue.
"While Canigen Lepto2 is still perfectly suitable in many cases and provides a broad spectrum of protection, the launch of Canigen Lepto4 helps to offer a solution for those who may needed a broader degree of protection through being at a higher risk or those which travel abroad."
CVS has announced the official opening of Lumbry Park Veterinary Specialists, a new small animal referral hospital in Alton, Hampshire.
The hospital was officially opened last Saturday by the Town Mayor of Alton during an open day attended by local dignitaries, about a hundred vets and representatives from the veterinary industry and various animal charities. Dr Caner Salih, a consultant cardiac surgeon at the Evelina London Children's Hospital was a special guest.
CVS says it has invested more than £4.3 million to create one of the most advanced, multi-disciplinary specialist veterinary hospitals in the UK. It occupies 1,300 square metres and employs forty people, including nine referral clinicians (seven of whom are boarded specialists), support and admin staff.
Lumbry Park offers a range of advanced diagnostics and treatments for dogs and cats across a range of specialties, including high-field MRI and CT scanning, key-hole surgery, interventional cardiac procedures, and joint replacements. Cardiology specialist Dr Luca Ferasin is Lumbry Park's Clinical Director, reporting to Professor John Innes, CVS' Referral Director.
Simon Innes, Chief Executive of CVS, pictured fifth from left, said: "The opening of Lumbry Park is a proud moment for CVS and the culmination of a huge amount of work by John, Luca and the team involved. They have worked together to create a fantastic environment in which our specialists can offer the highest standard of veterinary care to our patients and their owners and we are delighted to bring their expertise to veterinary practices and their clients right across the South East of England."
CVS Referral Director, Professor John Innes said: "The opening of Lumbry Park marks a major step for CVS in terms of investment in veterinary specialist services and we will work to ensure that it develops an international reputation for the standard of care it provides. The Hospital is easily accessible and has the space and rural setting to provide a professional and pleasant environment for our patients, their owners, and our team. Luca and his excellent team are raring to go and we look forward to welcoming our first patients next week."
Alton Town Mayor Mrs Pam Jones added: "I am delighted that Alton has been chosen as the location for such a prestigious veterinary centre and I am honoured to be asked to open it."
The University of Glasgow, School of Veterinary Medicine, is calling for help with research into the prevalence of pseudopregnancy in spayed bitches.
The research takes the form of a survey being conducted amongst a representative sample of veterinary surgeons by Pippa Hutchison, Dr Tim Parkin, Caroline Warnes and Dr Philippa Yam.
In particular, the research aims to gather data looking into how often veterinary surgeons are diagnosing and treating pseudopregnancy, and how frequently the condition occurs both before and after spaying.
Tanya Leslie MRCVS from Ceva Animal Health, sponsors of the work, said: “Ceva is delighted to have been given the opportunity to support this work to investigate and raise awareness of this important issue”.
The questionnaire is being sent out towards the end of this month. If you're one of the recipients, there's the added incentive of being entered into a draw for a £300 cash prize if you complete the questionnaire and return it by the 13th November.
The researchers say that after this initial work, they plan a prospective study establishing the wider incidence of pseudopregnancy in both entire and spayed bitches.
The RCVS is seeking applicants for an Appointment Group which will be responsible for deciding the membership for the governing body of the new RCVS Fellowship.
In June, RCVS Council approved proposals to develop a new style Fellowship to move it away from being an examination-based award to a formal learned society with routes to entry for those veterinary surgeons who can demonstrate meritorious contributions to clinical practice, to the profession or to learning. The Fellowship by thesis route has been discontinued as of 1 August 2015, although all applications received by this route prior to that date are being processed.
The new Fellowship will be governed and administered by a Fellowship Board with an additional Credentials Panel of up to 30 members to review new applications.
The College says it is now in the process of putting together an Appointment Group which will decide the membership of the Fellowship Board and the Credentials Panel. It is currently seeking to appoint a veterinary surgeon in the earlier stage of their career to the Group. The full details of the role, including details of the person specification, how to apply and information on expenses and remuneration can be found at www.rcvs.org.uk/workforus
The Group will be chaired by former RCVS President Lord Trees with other members being RCVS President Dr Bradley Viner and BVA President Sean Wensley as well as a lay observer. The first meeting of the Appointment Group is likely to take place before the end of the year and, once the Fellowship Board and Credentials Panel are established, the Group will be dissolved.
For an informal chat about the role before applying, contact Dr Simon Wallace, RCVS Education and Scientific Officer, on s.wallace@rcvs.org.uk or 020 7202 0702.
Her Majesty The Queen has today opened the University of Surrey's new £45m School of Veterinary Medicine, accompanied by His Royal Highness The Duke of Edinburgh.
Her Majesty and His Royal Highness toured the Large Animal Clinical Skills Building, where they met students taking equine examinations and working with livestock. The Royal Party also viewed a demonstration in the Biomechanics Laboratory, meeting Professor Noel Fitzpatrick and dogs that have benefitted from prosthetic limb surgery. They also watched teaching sessions in the Clinical Skills Laboratory, meeting staff and students.
After the tour, The Queen, The Duke and assembled guests attended a short ceremony to celebrate the opening of the new teaching facilities, during which Her Majesty unveiled a plaque to mark the occasion.
As The Royal Party left, they were bid farewell by Joey, the star of the theatre production War Horse.
Professor Michael Kearney, Vice-Chancellor of the University of Surrey, said: “We are hugely honoured to welcome Her Majesty and His Royal Highness to the University of Surrey. This is a very special occasion that tops off an exceptional start to the academic year for the University, after the launch of our 5G Innovation Centre and achieving The Times and Sunday Times ‘University of the Year’ accolade.
“The School of Veterinary Medicine further cements our position as a world-class institution that is delivering cutting-edge teaching and research from state-of-the-art facilities. It will not only provide the next generation of sought-after veterinary graduates, but it will offer significant opportunities for collaboration between human and animal medical science professionals and public sector organisations.”
Professor Noel Fitzpatrick, one of the founding partners of the School of Veterinary Medicine, said: “I had a vision where we would deliver a degree structure which was truly focussed on what you dream about when you are sixteen years old, when you are desperate to become a vet. I fully intend to be part of a team that will kindle that fire throughout professional life to shine a light onto the world that badly needs ambassadors of purpose and integrity to be the caretakers of health on Earth, both now and for long after I’m gone and these new buildings will still be standing. This is our legacy, and we are intensely proud to be part of this evolution in health education.”
The RCVS Disciplinary Committee has reprimanded Gloucestershire veterinary surgeon Adele Lewis for failing to pass on information about a horse’s clinical history to a potential buyer during a pre-purchase examination.
Ms Lewis, the sole principal of the Cotswold Equine Clinic in Lechlade, Gloucestershire, carried out the examination of a pony called Luke on 13 February 2014. Luke was owned by Mrs Booth who was a long-established client of Ms Lewis, both at her previous practice, Bourton Vale, and at her current practice. The examination was carried out on behalf of the prospective purchaser, Mrs Grieve.
Upon examination Ms Lewis certified that, in her opinion, Luke’s veterinary history did not increase the risk of purchase.
Following the purchase of Luke, Mrs Grieve attempted to obtain insurance for Luke and found out from a pet insurance company that a claim had been made by Mrs Booth in September 2013. She subsequently found out that, following concerns expressed by Mrs Booth and her trainer about Luke’s movement and their wanting an expert opinion, Ms Lewis had referred him to Dr Kold, a Specialist in Equine Orthopaedics, in September 2013. Dr Kold had diagnosed Luke with lameness and had given him intra-articular medication. Luke had also had a follow-up appointment with Dr Kold about four weeks later in October 2013.
The Disciplinary Committee hearing commenced on Tuesday 13 October 2015. At the outset, Ms Lewis admitted several parts of the charges (charge A and charge B) against her. In regards to charge A, she admitted that she had failed to inform Mrs Grieve that, when she examined Luke on 24 September 2013, his then owner Mrs Booth had complained firstly that Luke was “not tracking up and going forward” and, secondly, that he had improved significantly when put on a Phenylbutazone trial. She also admitted that she had referred him to Dr Kold for a poor performance investigation and that she ought to have informed Mrs Grieve of these matters.
In regards to charge B, she admitted that she completed a Certificate of Veterinary Examination in which she had declared that Luke’s veterinary history did not increase the risk of purchase and allowed the vendor’s declaration to include assertions that there had been no previous lameness and no intra-articular medication given in the last 12 months. Ms Lewis admitted that she ought to have known that her declaration that Luke’s veterinary history did not increase the risk of purchase was incorrect.
However, Ms Lewis denied being aware that Dr Kold had diagnosed lameness, administered an intra-articular corticosteroid to Luke and examined and noted a problem with his breathing, including upper airway disease and possible lower airway disease. Furthermore, she denied dishonesty in regards to both the charges against her and in relation to vendor declarations made on the Certificate of Veterinary Examination regarding previous lameness and intra-articular medication.
During the course of the hearing, Ms Lewis told the Committee that she had not received the reports about the two consultations by Dr Kold (despite their having been sent to her by letter and, with respect to the second report, also by email) and that she was therefore unaware of his findings when she carried out the pre-purchase examination. She also stated that she had not been informed of these by Mrs Booth. During her evidence, Ms Lewis also admitted having entered inaccurate information on a veterinary report to assist with an insurance claim.
The Committee did not find Ms Lewis to be an impressive witness citing the fact that her “explanations as to her practice showed a worrying absence of probity in the completion of veterinary reports for the purposes of insurance claims, and an absence of any effective practice management, consistent with acceptable practice.”
However, the Committee felt it did not have the evidence to conclude that Ms Lewis had acted dishonestly during the pre-purchase examination. It cited the fact that her actions, when informed by the purchaser Mrs Grieve of Dr Kold’s examination, did not appear to be those of someone trying to cover their tracks.
In regards to charge A, the Committee also found that the “apparently chaotic manner in which Ms Lewis ran her practice, and her own opinion that the pony was sound, would appear to have led her to wrongly disregard these matters from disclosure.”
In making its decision on her conduct and sanction, the Committee said that Ms Lewis’ failure to fully communicate to Mrs Grieve all the relevant information about Luke’s veterinary history fell far short of the conduct expected from a veterinary surgeon. It also cited the utmost importance of a complete and accurate certification process, as made clear in the RCVS Code of Professional Conduct and the Twelve Principles of Certification.
Chitra Karve, chairing the Committee and speaking on its behalf, said: “The Committee continues to emphasise the importance of maintaining the integrity of veterinary certification in any aspect of practice. Mrs Grieve told this Committee that if she had been fully informed about Luke’s veterinary history she would not have purchased the pony. It is clear from the evidence that it affected Mrs Grieve’s ability to insure the pony. Ms Lewis has accepted that the information about Luke’s veterinary history, not having been disclosed, was capable of affecting the risk of purchase. The public are entitled to rely upon veterinary surgeons providing complete and accurate information, when certificates and reports are prepared.”
In mitigation, the Committee paid regard to Ms Lewis’ inexperience at running her own practice and found no issue with her competence or clinical ability as a veterinary surgeon. It concluded that she had acted out of character and that there was no financial motivation for her actions. It also found it “highly relevant that the facts admitted and found proved related to a single pre-purchase examination.”
It also noted that Ms Lewis has now put in place a practice management system and has shown insight into her actions, by taking active steps to better comply with her obligations under the Code of Professional Conduct. She had also made early admissions of guilt and made a full apology to both Mrs Grieve and the RCVS both at the outset of the hearing, and in her evidence.
Chitra Karve added: “Having had the opportunity of observing her demeanour at this hearing, the Committee believes that it is unlikely that she will repeat her conduct.... The Committee has concluded that an appropriate and proportionate response in this case is to reprimand Ms Lewis.”
The Society of Practising Veterinary Surgeons (SPVS) is putting out a last call to take part in the SPVS Salaries Survey 2015, open to everybody working in the veterinary profession.
The long-standing survey provides a benchmark for veterinary surgeons, nurses and support staff to see trends in pay and conditions. Designed to provide a complete picture of remuneration levels, the survey covers basic earnings, bonuses, dividends, overtime and benefits such as accommodation, car allowances, private medical insurance and pensions. It also includes questions on employment contracts, hours worked, out of hours and weekend working.
Peter Brown, SPVS Treasurer and author of the Salaries Survey said: “I have been compiling the survey results for a number of years but it never fails to enlighten me as to what is happening in the profession. I know it is also the go to reference guide when practices are recruiting to help ensure they are offering competitive salary packages.
“Participation in the survey is open to all and the more practices that take part, the more accurate and useful the information will be so we would urge everyone working in the veterinary profession to take a few minutes to complete the survey. It can be done online and the information is completely anonymous.”
To complete the survey online, visit www.spvs.org.uk or, for a printed version, telephone 01926 410545. The survey is open until 30 November 2015.
Norbrook has launched an Android version of its existing free iPhone app: ‘the Veterinary Excellence Tool’ (VET).
VET offers a range of functions to assist veterinary professionals and farmers including a product dosing calculator. The Android version has been developed to meet customer demand and has the same features as the Apple version which is available for both iPhones and iPads.
Norbrook highlights the following features of the app:
The app can be downloaded for free by searching for “Norbrook” in either app store.
For further information please contact Laura Holmes, E-Marketing Manager, laura.holmes@norbrook.co.uk or 01536 741147.